Westaim Net Total Equity Issued/Repurchased 2010-2024 | WEDXD
Westaim net total equity issued/repurchased from 2010 to 2024. Net total equity issued/repurchased can be defined as the sum of all preferred and common equity transactions regarding a company's own stock.
Westaim Annual Net Total Equity Issued/Repurchased
(Millions of US $) |
| 2023 |
$-64 |
| 2022 |
$-3 |
| 2021 |
$-1 |
| 2020 |
$ |
| 2019 |
$ |
| 2018 |
$ |
| 2017 |
$37 |
| 2016 |
$ |
| 2015 |
$172 |
| 2014 |
$132 |
| 2013 |
$0 |
| 2012 |
$-513 |
| 2011 |
$3 |
| 2010 |
$251 |
| 2009 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
CHEM-SPECIALTY |
$0.461B |
$0.009B |
|
The Westaim Corporation is a technology accelerator that ensures its technology investments have the leadership, strategy, and capital to get into the marketplace as quickly as possible. Currently, Westaim has technology investments in three of the most important and fastest growing sectors of the economy: biomedical (Westaim Biomedical Corp.), semi-conductor/electronics (iFire Technology Inc.), and e-business software (Savvion).
|
